Vault Health today published a white paper detailing one of its first active clinical trials. The Live BASIC Trial is studying whether a combination of specific probiotics can help increase immune protection against COVID-19. The pilot clinical trial is being done in partnership with Rutgers University, which Vault has worked with throughout the course of the pandemic through its national COVID testing efforts. “Probiotics are already thought to have a variety of health benefits. But one specific subset of probiotics – called OL-1 – may have an especially critical role in the fight against the global COVID-19 pandemic,” said Hady Khoury, President of Vault’s Life Sciences division and Chief Research Officer. “That’s because at a molecular level, OL-1 probiotics resemble parts of the SARS-CoV-2 coronavirus that causes COVID-19.” Khoury says the trial will hopefully shed light on whether that resemblance might coax the body to mount an immune response helpful in warding off COVID-19. To read the full story.